Sign in

CIK 0001746473

  • Non-accelerated filer
  • Smaller reporting company

PLIANT THERAPEUTICS, INC.

Sign in to watch
Ticker
PLRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
474272481
Phone
+1 650-481-6770
Business address
331 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO, CA, 94080
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2023-01-23 Coulie Bernard President and CEO Sale −4,850 $34.93 $169K 93,812
2023-01-23 Coulie Bernard President and CEO Sale −15,000 $35.00 $525K 434,317
2023-01-23 Coulie Bernard President and CEO Exercise or conversion · Stock Option (right to buy) −15,000 232,380
2023-01-23 Ouimette Mike General Counsel & Corp. Sec'y Exercise or conversion +10,000 $11.86 $119K 15,947
2023-01-23 Ouimette Mike General Counsel & Corp. Sec'y Exercise or conversion +10,000 $24.32 $243K 25,947
2023-01-23 Ouimette Mike General Counsel & Corp. Sec'y Sale −20,000 $34.19 $684K 5,947
2023-01-23 Ouimette Mike General Counsel & Corp. Sec'y Exercise or conversion · Stock Option (right to buy) −10,000 77,000
2023-01-23 Ouimette Mike General Counsel & Corp. Sec'y Exercise or conversion · Stock Option (right to buy) −10,000 98,240
2023-01-23 Lefebvre Eric Chief Medical Officer Sale −67,500 $34.48 $2.3M 76,926
2023-01-23 Cummings Keith Lamont Chief Financial Officer Exercise or conversion +12,500 $2.08 $26K 96,924
2023-01-23 Cummings Keith Lamont Chief Financial Officer Exercise or conversion +17,500 $6.22 $109K 114,424
2023-01-23 Cummings Keith Lamont Chief Financial Officer Sale −30,000 $35.00 $1.1M 84,424
2023-01-23 Cummings Keith Lamont Chief Financial Officer Exercise or conversion · Stock Option (right to buy) −12,500 133,597
2023-01-23 Cummings Keith Lamont Chief Financial Officer Exercise or conversion · Stock Option (right to buy) −17,500 18,198
2023-01-19 Cheung Lily Chief Human Resource Officer Grant or award · Stock Option (Right to Buy) +123,000 123,000
2023-01-09 Coulie Bernard President and CEO Exercise or conversion +5,000 $2.08 $10K 98,812
2023-01-09 Coulie Bernard President and CEO Sale −5,000 $19.17 $96K 93,812
2023-01-09 Coulie Bernard President and CEO Exercise or conversion · Stock Option (right to buy) −5,000 247,380
2023-01-06 Coulie Bernard President and CEO Exercise or conversion +15,000 $2.08 $31K 108,812
2023-01-06 Coulie Bernard President and CEO Sale −15,000 $19.04 $286K 93,812

Page 12 of 19 · 379 trades